Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMNN
IMNN logo

IMNN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Imunon Inc (IMNN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
2.120
1 Day change
-2.75%
52 Week Range
41.220
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

IMNN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading in pre-market at $2.37 with a modest gain, but the technical trend remains weak, there is no supportive options or insider/catalyst flow, and the near-term probability profile points lower. With no strong proprietary buy signal and no recent news-driven momentum, the better call is to stay out and avoid initiating a long-term position at this level.

Technical Analysis

The technical picture is bearish. MACD histogram is negative at -0.0121 and still below zero, showing weak momentum. RSI_6 at 42.977 is neutral but leaning soft, not indicating a strong rebound. The moving averages are aligned bearishly with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend structure. Price is near the pivot at 2.337, with resistance at 2.554 and 2.688, while support sits lower at 2.119 and 1.985. The short-term trend data also suggests weakness, with a 70% chance of -1.12% next day, -2.66% next week, and -11.28% next month. Overall, the trend is weak and does not support a long-term entry right now.

Positive Catalysts

  • The only clear positive catalyst is the recent analyst initiation from Maxim on 2026-04-17 with a Buy rating and a $10 price target, which is far above the current price and shows some upside belief from Wall Street. Pre-market trading is also slightly positive at 2.37 (+3.04%), but that is not enough on its own to override the weak technical setup.

Neutral/Negative Catalysts

  • No news in the recent week, so there is no event-driven momentum to support the stock. Hedge funds are neutral and insiders are neutral, with no significant trading trends over the last quarter or month. There is no congress trading activity in the last 90 days. The technical setup is bearish, and the modeled short-term stock trend points to downside.

Financial Performance

No financial snapshot was available because of a data error, so the latest quarter financial performance cannot be assessed from the provided information.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst sentiment is mildly positive but limited: Maxim initiated coverage on 2026-04-17 with a Buy rating and a $10 price target. That is a constructive sign and implies meaningful upside from current levels. However, it is only one coverage event in the data, and there is no broader trend of multiple upgrades or target increases. Wall Street's pros view is that IMNN may have upside potential if execution improves; the cons view is that the current price action, weak momentum, and lack of confirming catalysts make the stock unattractive right now.

Wall Street analysts forecast IMNN stock price to rise
1 Analyst Rating
Wall Street analysts forecast IMNN stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.150
sliders
Low
12
Averages
12
High
12
Current: 2.150
sliders
Low
12
Averages
12
High
12
Maxim
Buy
initiated
$10
AI Analysis
2026-04-17
Reason
Maxim
Price Target
$10
AI Analysis
2026-04-17
initiated
Buy
Reason
Maxim initiated coverage of Imunon with a Buy rating and $10 price target.

People Also Watch